As Novo Nordisk’s patent expires on March 20, Sun Pharma, Dr Reddy’s, Zydus and Mankind enter the market after months of ...
Stay updated with the Sun Pharma Stock Liveblog, your one-stop destination for real-time information and analysis of a leading stock. Explore the latest updates on Sun Pharma stock, including: Last ...
GlobalData on MSN
FDA accepts Sun Pharma’s Ilumya sBLA for psoriatic arthritis
Ilumya has secured marketing authorisations from more than 55 health authorities worldwide.
July 31 (Reuters) - Sun Pharmaceutical Industries (SUN.NS), opens new tab, India's largest drugmaker by revenue, reported a higher adjusted profit on Thursday, aided by strong domestic sales. The ...
NDTV Profit on MSN
From Dr. Reddy's to Sun Pharma — which Indian players will make the most out of Ozempic patent expiry?
Industry executives expect an initial wave of more than a dozen brands within weeks, with dozens more following over the year, triggering intense price competition.
Sun Pharmaceutical Industries Ltd. closed 2.99% short of its 52-week high of 1,850.95 rupees, which the company achieved on May 2nd.
Sun Pharmaceutical Industries Ltd. settled claims worth $200 million in an antitrust case in Pennsylvania alleging that the firm, along with others, colluded to fix prices of generic drugs. The units ...
Track Sun Pharmaceutical Industries share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results